Literature DB >> 31312686

Effectiveness of Methylene Blue in the Prevention of Stifle Joint Arthrofibrosis in Rabbit Models.

Hamid Namazi1,2,3, Mohammad J Emami1,2,3, Fatemeh Dehghani Nazhvani1,2,3, Ali Dehghani Nazhvani1,2,3, Zeinab Kargarshouroki1,2,3.   

Abstract

BACKGROUND: One of the major challenges in orthopedic surgery is the prevention of arthrofibrosis, which can be successfully alleviated in its early stages. Many studies suggest the administration of methylene blue (MB) as an accessible and effective agent for the prevention of post-operation adhesions. The purpose of this study was to evaluate the efficacy of MB in the prevention of arthrofibrosis.
METHODS: This study was conducted on 18 New Zealand white female mature rabbits. The anterior cruciate ligament of the left stifle joint of each animal was cut during aseptic surgery. In the next step, the rabbits were divided into three groups based on their treatments. The rabbits in the first, second, and third groups were subjected to the injection of normal saline, 1% MB solution, and 2% MB solution into their synovial space, respectively. The postoperative stifle range of motion was measured every week. After 4 weeks, the animals were euthanized and all joints were dissected for histopathology.
RESULTS: The histopathological evaluation of tissues indicated the presence of fibrotic connective tissue as a sign of fibrosis in all groups. The fibrosis rate, inflammatory rate, tissue disarrangement, fibroblastic cellularity, and granulation tissue formation were at their highest levels in the 1% MB group. The integrity of articular cartilage in the 2% MB group was lower than the other groups. The level of bone degeneration was similar in both MB groups; however, it was more than the control saline group. The range of motion was reduced during the first week, then increased in the second and third weeks, and finally decreased in the fourth week.
CONCLUSION: The MB was not an effective method regarding the prevention or treatment of arthofibrosis and the subsequent osteoarthritis. In contrast with previous studies, fibrosis was lower in the high dose MB group, compared to the low dose MB group. The alterations in the range of motion were related to the reduced movement caused by the pain and stiffness of the operated joints. The current study can be considered as the first report addressing the adverse effect of MB on synovial components. LEVEL OF EVIDENCE: I.

Entities:  

Keywords:  Anterior cruciate ligament; Arthrofibrosis; Fibrosis; Methylene blue; tifle joint

Year:  2019        PMID: 31312686      PMCID: PMC6578471     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  29 in total

Review 1.  Methylene Blue--a therapeutic dye for all seasons?

Authors:  M Wainwright; K B Crossley
Journal:  J Chemother       Date:  2002-10       Impact factor: 1.714

2.  The influence of locally applied platelet-derived growth factor-BB on free tendon graft remodeling after anterior cruciate ligament reconstruction.

Authors:  Andreas Weiler; Cornelius Förster; Patrick Hunt; Roman Falk; Tobias Jung; Frank N Unterhauser; Volker Bergmann; Gerhard Schmidmaier; Norbert P Haas
Journal:  Am J Sports Med       Date:  2004-06       Impact factor: 6.202

3.  Mitomycin C effect on fibrous adhesions of rabbit temporomandibular joint.

Authors:  Erdinc Aydin; Sina Uckan; B Handan Ozdemir; Pinar Uyar
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

4.  Reduction in formation of peritoneal adhesions by methylene blue in rats: a dose response study.

Authors:  Y Kluger; A Weinbroum; R Ben-Avraham; Y Galili; J Klausner; M Rabau
Journal:  Eur J Surg       Date:  2000-07

5.  Adhesion reduction after knee surgery in a rabbit model by Hyaloglide, a hyaluronan derivative gel.

Authors:  G Brunelli; C Longinotti; C Bertazzo; A Pavesio; D Pressato
Journal:  J Orthop Res       Date:  2005-07-20       Impact factor: 3.494

6.  Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury.

Authors:  S C Salaris; C F Babbs; W D Voorhees
Journal:  Biochem Pharmacol       Date:  1991-07-15       Impact factor: 5.858

7.  Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani: results of 30 cases.

Authors:  B B Mentes; M Akin; S Leventoglu; F A Gultekin; M Oguz
Journal:  Tech Coloproctol       Date:  2004-03       Impact factor: 3.781

8.  Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain.

Authors:  Baogan Peng; Yingmin Zhang; Shuxun Hou; Wenwen Wu; Xiaobing Fu
Journal:  Eur Spine J       Date:  2006-02-22       Impact factor: 3.134

9.  The effects of methylene blue on lung injury in septic rats.

Authors:  S Demirbilek; E Sizanli; N Karadag; A Karaman; N Bayraktar; E Turkmen; M O Ersoy
Journal:  Eur Surg Res       Date:  2006-02-14       Impact factor: 1.745

10.  Effects of diazeniumdiolates (NONOates) and methylene blue on the reduction of postoperative adhesion in rats.

Authors:  Meral Cetin; Bulent Duran; Nihal Demirkoprulu; Tevfik Guvenal; Omur Erden; Ali Cetin
Journal:  Gynecol Obstet Invest       Date:  2004-01-29       Impact factor: 2.031

View more
  1 in total

1.  Effect of methylene blue on experimental postoperative adhesion: A systematic review and meta-analysis.

Authors:  Su Hyun Seo; Geun Joo Choi; Oh Haeng Lee; Hyun Kang
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.